Skip to main content

UBS Oconnor LLC

SEC CIK
0001132716
Latest filing
Aug 14, 2026

CDLX holding history

Cardlytics, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CDLX overviewAll 13F holders of CDLXFull Q4 2025 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q1 2021
Holdings of CDLX by UBS Oconnor LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−450,000−100.0%Sold outHolders
Q4 2024450,000$1.67M<0.1%00.0%UnchangedHolders
Q3 2024450,000$1.44M<0.1%−294,780−39.6%ReducedHolders
Q2 2024744,780$6.11M0.2%+319,780+75.2%AddedHolders
Q1 2024425,000$6.16M0.2%+225,000+112.5%AddedHolders
Q4 2023200,000$1.84M0.1%+200,000NewHolders
Q4 20210$00.0%−65,000−100.0%Sold outHolders
Q3 202165,000$5.46M<0.1%−5,000−7.1%ReducedHolders
Q2 202170,000$8.88M0.1%00.0%UnchangedHolders
Q1 202170,000$7.68M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.